
Rocket Pharmaceuticals Inc (RCKT)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -35.275 | -25.492 | -42.209 | -24.789 | -29.015 | -31.083 | -42.307 | -43.929 |
Return on Equity (%) | -47.097 | -48.783 | -61.636 | -30.826 | -34.459 | -35.287 | -46.984 | -50.006 |
Return on Invested Capital (%) | -36.317 | -24.008 | -44.027 | -26.42 | -31.401 | -36.021 | -53.373 | -61.222 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 2.711 | 6.764 | 3.616 | 5.044 | 7.75 | 6.572 | 5.369 | 4.75 |
Earnings Per Share | -1.588 | -4.177 | -1.651 | -1.411 | -2.29 | -2.621 | -2.804 | -2.724 |
Cash Per Share | 1.104 | 11.147 | 2.467 | 3.385 | 4.871 | 3.607 | 1.776 | 0.62 |
Working Capital Per Share | 4.489 | 13.732 | 4.291 | 5.285 | 7.455 | 5.734 | 4.106 | 3.657 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.588 | -4.177 | -1.651 | -1.411 | -2.29 | -2.621 | -2.804 | -2.724 |
EBITDA Per Share | -1.588 | -4.177 | -1.651 | -1.411 | -2.29 | -2.621 | -2.804 | -2.724 |
Free Cash Flow Per Share | -1.576 | -4.195 | -1.626 | -0.994 | -1.999 | -2.586 | -2.775 | -2.62 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 26.99M | 6.81M | 45.15M | 54.77M | 61M | 64.51M | 79.12M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 79.12M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 937.28M |
Price to Earnings Ratio | -0.03 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.11 |
Price to Book Ratio | 0.01 |
Dividend Yield | - |
Shares Outstanding | 106.63M |
Average Volume (1 week) | 1.5M |
Average Volume (1 Month) | 1.23M |
52 Week Change | -72.30% |
52 Week High | 30.94 |
52 Week Low | 8.25 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.